⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRO News
Spero Therapeutics, Inc. Common Stock
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
globenewswire.com
SPRO
Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
prnewswire.com
SPRO
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
globenewswire.com
SPRO
The Eye Drink Achieves Verified Brand Status on RangeMe, Expanding Visibility to Retail Buyers Nationwide
accessnewswire.com
WMT
CVS
NDSN
SPRO
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
globenewswire.com
CMPS
SPRO
Form 8-K
sec.gov
SPRO
Form 8-K
sec.gov
SPRO
Syndigo Conversion Framework Helps Brands and Retailers Unlock Growth on Every Shelf
globenewswire.com
SJM
DOLE
SWK
CL
UL
SPRO
AZO
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
globenewswire.com
SPRO
GSK
Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes
globenewswire.com
SPRO